FDA Panel To Review Safety Of Contrast Agent

Law360, New York (June 23, 2008, 12:00 AM EDT) -- In the wake of a wave of product liability lawsuits over contrast agents, the U.S. Food and Drug Administration has appointed an independent panel of experts to review the safety of the products used to enhance echocardiogram heart imaging tests.

An advisory committee on cardiovascular and renal drugs is slated to meet Tuesday to review the history of currently marketed ultrasound contrast agents. The committee will also obtain opinions from advisers regarding safety considerations in the development of these agents, the FDA said in documents posted...
To view the full article, register now.